Quarterly report [Sections 13 or 15(d)]

Restatement of Previously Issued Condensed Consolidated Financial Statements

v3.26.1
Restatement of Previously Issued Condensed Consolidated Financial Statements
3 Months Ended
Mar. 31, 2026
Accounting Changes and Error Corrections [Abstract]  
Restatement of Previously Issued Condensed Consolidated Financial Statements

Note 16 - Restatement of Previously Issued Condensed Consolidated Financial Statements

 

For the three months ended March 31, 2026, the Company determined that it had not appropriately presented its condensed consolidated balance sheets, statement of operations, statement of shareholders’ equity (deficit), and statement of cash flows due to the errors related to revenue, cost of goods sold and deferred revenue.

 

Based on an analysis of FASB ASC 250, Accounting Changes and Error Corrections, Staff Accounting Bulletin (“SAB”) No. 99, Materiality, and SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, the Company concluded that these errors were material to the previously issued interim condensed consolidated financial statements and therefore required a restatement.

 

The restatement impacts to the Company’s condensed consolidated balance sheet were as shown below (amount in thousands):

 

 

                         
    As of March 31, 2026  
    As Previously              
    Reported     Adjustments     As Restated  
ASSETS                        
Current assets                        
Prepaid expenses and other current assets   $ 1,469     $ (263 )   $ 1,206  
Total current assets     3,113       (263 )     2,850  
TOTAL ASSETS   $ 58,730     $ (263 )   $ 58,467  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY                        
Current liabilities                        
Accounts payable     14,169       385       14,554  
Deferred revenue     1,840       (827 )     1,013  
Total current liabilities     56,108       (442 )     55,666  
Total liabilities     59,344       (442 )     58,902  
                         
Stockholders’ equity (deficit)                        
Accumulated deficit     (78,490 )     179       (78,311 )
Total stockholders’ equity (deficit)     (614 )     179       (435 )
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ 58,730     $ (263 )   $ 58,467  

 

The restatement impacts to the Company’s condensed consolidated statements of operations were as shown below (amount in thousands, except per share amounts):

 

                         
    For the three months ended  
    March 31, 2026  
    As Previously              
    Reported     Adjustments     As Restated  
Revenues, net   $ 478     $ 691     $ 1,169  
Cost of revenues     311       563       874  
Gross profit     167       128       295  
                         
Operating expenses:                        
General and administration     2,772       (51 )     2,721  
Loss from operations     (2,605 )     179       (2,426 )
                         
Loss from operations before income taxes     (3,980 )     179       (3,801 )
Loss from continuing operations after income taxes     (5,354 )     179       (5,175 )
Net loss   $ (5,354 )   $ 179     $ (5,175 )
                         
Net earnings (loss) per share:                        
Loss from continuing operations, basic and diluted   $ (0.43 )   $ 0.01     $ (0.42 )
Net loss (earnings) per share, basic and diluted   $ (0.43 )   $ 0.01     $ (0.42 )

 

 

The restatement impacts to the Company’s condensed consolidated statements of changes in stockholders’ equity were as shown below (amount in thousands):

 

    Accumulated Deficit    

Total

Stockholders’ Deficit

 
    For the three months ended  
    March 31, 2026  
    Accumulated Deficit    

Total

Stockholders’ Deficit

 
As Previously Reported              
Net loss   $ (5,354 )   $ (5,354 )
Balance at March 31, 2026   $ (78,490 )   $ (614 )
                 
Adjustments   $ 179     $ 179  
                 
As Restated            
Net loss   $ (5,175 )   $ (5,175 )
Balance at March 31, 2026   $ (78,311 )   $ (435 )

 

 

The restatement impacts to the Company’s condensed consolidated statement of cash flows were as shown below (amount in thousands):

 

                         
    For the three months ended  
    March 31, 2026  
    As Previously              
    Reported     Adjustments     As Restated  
Cash flows from operating activities:                        
Net loss from continuing operations   $ (5,354 )   $ 179     $ (5,175 )
Changes in operating assets and liabilities:                        
Prepaid expenses and other current assets     (104 )     263       159  
Accounts payable and accrued expenses     1,180       385       1,565  
Deferred revenue     484       (827 )     (343 )
Net cash used in operating activities - continuing operations     (748 )     -       (748 )
Net cash used in operating activities   $ (748 )   $ -     $ (748 )